Featured Testimonials
System Owner
UK-based, Multinational Pharmaceutical and Biotechnology Company
Medicinal Products
Regulatory Affairs
UK
Thank You, Freyr team, for a Fantastic 2019! The OTC DOCS TD user community feels better supported despite the technical challenges and system constraints. Thank you for being the voice to represent their ways of working and helping us design a more user-friendly and effective system going forward.
Assistant Manager | Global Regulatory Affairs
South Korea-based, Global Biopharmaceutical Company
Medicinal Products
Regulatory Affairs
South Korea
Completing the CTD writing project with Freyr was really helpful and cooperative. Thank you very much for your support and effort. Freyr Solutions very well understand the 'Asian culture'; sometimes, we ask for completing the project in stringent timelines, but Freyr accepts this kind of urgent request and completes them on time.
CEO
US-based, CRO Company that Focuses on Material Science and Engineering for Drug Development
Medicinal Products
Regulatory Affairs
USA
Many thanks for your efforts, especially at the last minute.
SVP - R&D ( Finished Dosage Form)
US-based, CRO Company that Focuses on Material Science and Engineering for Drug Development
Medicinal Products
Regulatory Affairs
USA
Kudos to you all for the brilliant teamwork!!! Alone, we can do so little; together, we can do so much. Look forward to the next milestone and collaboration on new projects in the future.
Regulatory Affairs (Formulation R&D)
US-based, CRO Company that Focuses on Material Science and Engineering for Drug Development
Medicinal Products
Regulatory Affairs
USA
Thanks a lot for your extended support at the last moment. We really appreciate your amazing dedication and efforts.
Vice President R&D
Canada-based, Leading OTC Products Company
Medicinal Products
Regulatory Affairs
Canada
Thanks for sending the invoice. The activities and amounts generally mesh with our expectations. The provided resource is doing a great job managing our projects and keeping us informed of the status. We are very happy with her diligence, professionalism, and high level of service. For tracking these types of hourly activities in our internal records, it would be helpful if you could provide a summary of the hours by month or by country if that is possible.
Regulatory Affairs Manager
US-based, Leading Pharmaceutical-grade Chemicals Manufacturing Company
Medicinal Products
Regulatory Affairs
USA
I honestly can't think of any suggestions for improvement at Freyr's end. As I've said before, Freyr is terrific to work with, more so than any other consultant I've dealt with. Freyr's team was all incredibly responsive, helpful and met every timeline as they stated originally. I was very impressed with the team's professionalism and kindness. I mean it when I say I hope to work with Freyr on additional projects. I'll be reaching out to the team soon with details of future projects.
Thank you, everyone at Freyr, for your excellent efforts – it is sincerely appreciated!
Regulatory Consultant
US-based, Leading Pharmaceuticals Manufacturing Company
Medicinal Products
Regulatory Affairs
USA
Please relate to the team the excellent job they have done on the IND reactivation. Specifically, the high-quality module 3, written by Freyr. It was very comprehensive, very few revisions were required, and we had no questions from Health Canada or FDA. No CMC questions; that was a first for me. So very responsive to my many requests, which I am sure can be frustrating but always helpful while producing excellent work.
Thank you for always being available and responding quickly and comprehensively to all my requests.
What a great team you have, Freyr.
System Owner
UK-based, Multinational Pharmaceutical and Biotechnology Company
Medicinal Products
Regulatory Affairs
UK
Thank you, Freyr, for all your help with the informal testing, constructive feedback, and positive engagement.
Quality Control and Regulatory Manager
US-based, Nutraceutical Products Manufacturing Company
Medicinal Products
Regulatory Affairs
USA
This project, eCTD DMF conversion, was against a very tight schedule and required dedicated resources. Freyr provided the dedicated resources needed to meet our immediate Regulatory filing requirements. Freyr was always on schedule/or exceeded the dates outlined in the project plan. All changes were handled within 24 hours, and notifications of changes were promptly provided. This project is not yet complete but has been very successful until this point.